The effect of skin permeation enhancers on the formation of porphyrins in mouse skin during topical application of the methyl ester of 5-aminolevulinic acid

被引:9
作者
Bugaj, A
Juzeniene, A
Juzenas, P
Iani, V
Ma, LW
Moan, J
机构
[1] Karol Marcinkowski Univ Med Sci, Dept Clin Pharm & Biopharm, PL-61861 Poznan, Poland
[2] Norwegian Radium Hosp, Inst Canc Res, Dept Radiat Biol, N-0310 Oslo, Norway
[3] Univ Oslo, Inst Phys, N-0316 Oslo, Norway
关键词
porphyrins; normal mouse skin fluorescence; in vivo direct skin fluorescence measurement; methyl; 5-aminolevulinate; topical application; permeation enhancers;
D O I
10.1016/j.jphotobiol.2005.12.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The influence of skin permeation enhancers, such as dimethyl sulphoxide (DMSO) and 1-[2-(decylthio)ethyl]azacyclopentan-2-one (HPE-101), Labrafac((R))CC, Labrafil((R)), Labrasol((R)) and Transcutol((R)) in a concentration of 10% (wt./wt.) on the formation of porphyrins in normal mouse skin from topical application of creams with methyl 5-aminolevulinate (MAL) was studied. The concentration of porphyrins in the mouse skin was determined by direct fluorescence measurements. The results show that studied permeation enhancers increase the formation of porphyrins, and therefore also the skin penetration 21K MAL whereas for 10% and 20% (wt./wt.) MAL concentrations only DMSO, HPE-101 and Labrafac((R))CC increased the porphyrin formation. At all studied MAL concentrations DMSO gave the largest enhancing effect, similarly to that of HPE-101. This suggests that in 2-20% MAL creams HPE-101 may be substituted by Labrafac((R))CC to reduce skin irritation induced by HPE-101 without impairing the porphyrin formation. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:94 / 97
页数:4
相关论文
共 20 条
  • [1] ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization
    Casas, A
    Perotti, C
    Fukuda, H
    Rogers, L
    Butler, AR
    Batlle, A
    [J]. BRITISH JOURNAL OF CANCER, 2001, 85 (11) : 1794 - 1800
  • [2] In vitro metabolism of 5-ALA esters derivatives in hairless mice skin homogenate and in vivo PpIX accumulation studies
    De Rosa, FS
    Lopez, RFV
    Thomazine, JA
    Tedesco, AC
    Lange, N
    Bentley, MVLB
    [J]. PHARMACEUTICAL RESEARCH, 2004, 21 (12) : 2247 - 2252
  • [3] Modified topical photodynamic therapy of superficial skin tumors, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia
    Harth, Y
    Hirshowitz, B
    Kaplan, B
    [J]. DERMATOLOGIC SURGERY, 1998, 24 (07) : 723 - 726
  • [4] Hsu T.-M., 2004, United States patent no, Patent No. [US6835392, 6835392]
  • [5] Kennedy J C, 1996, J Clin Laser Med Surg, V14, P289
  • [6] Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone
    Kim, HJ
    Yoon, KA
    Hahn, M
    Park, ES
    Chi, SC
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (05) : 523 - 529
  • [7] Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10:: formulation development and bioavailability assessment
    Kommuru, TR
    Gurley, B
    Khan, MA
    Reddy, IK
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 212 (02) : 233 - 246
  • [8] Reorganization of lipid nanocapsules at air-water interface 3.: Action of hydrolytic enzymes HLL and pancreatic PLA2
    Minkov, I
    Ivanova, T
    Panaiotov, I
    Proust, J
    Verger, R
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2005, 45 (01) : 24 - 34
  • [9] MINKOV I, 2005, COLLOIDS SURG B, V44, P97
  • [10] Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters
    Moan, J
    Ma, LW
    Juzeniene, A
    Iani, V
    Juzenas, P
    Apricena, F
    Peng, Q
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (01) : 132 - 135